Business Context and Reporting Period
This Form 8-K Current Report was filed by Lipocine Inc. on April 15, 2014. The filing addresses corporate governance matters, specifically the scheduling of the 2014 Annual Meeting of Stockholders and the deadline for shareholder proposals.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on administrative and governance events rather than financial performance.
Material Changes
There are no material financial changes reported in this document. The primary event is the Board of Directors' approval to hold the 2014 Annual Meeting on Tuesday, June 10, 2014. Additionally, the Company noted that it did not hold an annual meeting in 2013, necessitating the establishment of a specific deadline for Rule 14a-8 stockholder proposals.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The only risk or contingency mentioned is the procedural requirement for stockholders to submit proposals by the close of business on April 26, 2014, to be included in the proxy statement.
Key Facts for Investors
- Annual Meeting Date: June 10, 2014.
- Proposal Deadline: April 26, 2014, for inclusion in the 2014 proxy statement.
- Historical Context: No annual meeting was held in 2013.
- Submission Address: Proposals must be sent to the Company Secretary at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.